trending Market Intelligence /marketintelligence/en/news-insights/trending/Y8wNE2pkH0Q8LJ0PK8Mnag2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Japan's Terumo fiscal Q1 profit climbs 26% YOY

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Japan's Terumo fiscal Q1 profit climbs 26% YOY

Terumo Corp. said profit attributable to owners of the parent for the first quarter ended June 30 totaled ¥22.79 billion, a gain of 26% from ¥18.09 billion in the prior-year period.

EPS came in at ¥30.15, a 26.1% yearly increase from ¥23.91.

Revenue rose 6.6% year over year to ¥152.53 billion from ¥143.02 billion.

For fiscal year ending March 2020, the Japanese medical device maker expects profit attributable to owners of the parent to reach ¥81 billion, and revenue amounting to ¥635 billion.

Tokyo-based Terumo develops, manufactures and distributes medical devices and services worldwide.

As of Aug. 7, US$1 was equivalent to ¥105.70.